These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 32075801)
1. Fatty Acid Oxidation Controls CD8 Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801 [TBL] [Abstract][Full Text] [Related]
2. Functional Heterogeneity of CD4 Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P Front Immunol; 2018; 9():2654. PubMed ID: 30505306 [TBL] [Abstract][Full Text] [Related]
3. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13 Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519 [TBL] [Abstract][Full Text] [Related]
4. Reactive glia promote development of CD103 Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245 [TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of CD8 Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F Front Immunol; 2018; 9():1904. PubMed ID: 30158938 [TBL] [Abstract][Full Text] [Related]
7. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer. Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485 [TBL] [Abstract][Full Text] [Related]
8. High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma. Hill SL; Sugiyarto G; Harrington J; James E; Underwood TJ; Elliott T Cancer Immunol Immunother; 2024 Sep; 73(11):213. PubMed ID: 39235606 [TBL] [Abstract][Full Text] [Related]
9. Characterization of CD103 Han L; Gao QL; Zhou XM; Shi C; Chen GY; Song YP; Yao YJ; Zhao YM; Wen XY; Liu SL; Qi YM; Gao YF Cancer Immunol Immunother; 2020 Aug; 69(8):1493-1504. PubMed ID: 32285170 [TBL] [Abstract][Full Text] [Related]
11. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Pan Y; Tian T; Park CO; Lofftus SY; Mei S; Liu X; Luo C; O'Malley JT; Gehad A; Teague JE; Divito SJ; Fuhlbrigge R; Puigserver P; Krueger JG; Hotamisligil GS; Clark RA; Kupper TS Nature; 2017 Mar; 543(7644):252-256. PubMed ID: 28219080 [TBL] [Abstract][Full Text] [Related]
12. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer. Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173 [TBL] [Abstract][Full Text] [Related]
13. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma. Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027 [TBL] [Abstract][Full Text] [Related]
14. The expression of C-MYC in gastric adenocarcinoma is associated with PD-L1 and FOXP3 expression: C-MYC overexpression is a good prognostic factor. Won KY; Kim GY; Kim HK; Song MJ; Choi SI; Bae GE; Lim SJ Pathol Res Pract; 2019 Nov; 215(11):152639. PubMed ID: 31582185 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas. Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254 [TBL] [Abstract][Full Text] [Related]
16. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. Djenidi F; Adam J; Goubar A; Durgeau A; Meurice G; de Montpréville V; Validire P; Besse B; Mami-Chouaib F J Immunol; 2015 Apr; 194(7):3475-86. PubMed ID: 25725111 [TBL] [Abstract][Full Text] [Related]
17. Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma. Noh BJ; Kwak JY; Eom DW BMC Cancer; 2020 Jan; 20(1):58. PubMed ID: 31992245 [TBL] [Abstract][Full Text] [Related]
18. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8 Eissa IR; Mukoyama N; Abdelmoneim M; Naoe Y; Matsumura S; Bustos-Villalobos I; Ichinose T; Miyajima N; Morimoto D; Tanaka M; Fujimoto Y; Sone M; Kodera Y; Kasuya H Int J Cancer; 2021 Jul; 149(1):214-227. PubMed ID: 33687756 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Categorizing Gastric Carcinoma by PD-L1 Expression and Tumor Infiltrating Lymphocytes. Noh BJ; Kim JH; Eom DW Ann Clin Lab Sci; 2018 Nov; 48(6):695-706. PubMed ID: 30610038 [TBL] [Abstract][Full Text] [Related]
20. Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group. Chang H; Jung WY; Kang Y; Lee H; Kim A; Kim HK; Shin BK; Kim BH Oncotarget; 2016 Dec; 7(49):80426-80434. PubMed ID: 27741514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]